US Government Grants
Grants from government agencies, departments and institutes for
conferences in 2024 and 2023
Government support is crucial to Keystone Symposia's ability to recruit outstanding speakers, and to support student and postdoctoral scholarships. We gratefully acknowledge the generous support provided by the U.S. National Institutes of Health (NIH) and other government agencies:
Government support is crucial to Keystone Symposia's ability to recruit outstanding speakers, and to support student and postdoctoral scholarships. We gratefully acknowledge the generous support provided by the U.S. National Institutes of Health (NIH) and other government agencies:
2024 Conferences
National Cancer Institute (NCI)
Grant No. 1R13CA268652-01A1: Transposable Elements at the Crossroads of Evolution, Health and Disease (2024-F2)
Grant No. 1R13CA284827-01: B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics (2024-J1)
National Center for Advancing Translational Sciences (NCATS)
Grant No. 1Rl 3TR004287-01: Targeted Protein Degradation (2024-Q3)
National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1R13HL170501-01: Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment (2024-F1)
National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI179137-01: Vaccinology During and After COVID-19 (2024-F6)
Grant No. 1R13AI179138-01: T and B Cell Collaboration in Germinal Centers and Beyond (2024-J2)
Grant No. 1R13AI179139-01: Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade (2024-J4)
Grant No. 1R13AI179172-01: RNA Modifications in Health and Disease (2024-J7)
Grant No. 1R13AI179171-01: Inhibitory Receptors in Immune Homeostasis, Disease and Therapy (2024-A1)
Grant No. 1R13AI179140-01: Myeloid Cell Diversity: From Fundamental Biology to Disease States (2024-A3)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Grant No. 1R13AR083220-01: Exercise Biology: Signaling, Mechanisms and Benefits (2024-Q1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 1R13DK137546-01: Circulating Metabolic Intermediates as Fuels and Signals (2024-J3)
National Institute of Neurological Disorders and Stroke (NINDS)
Grant No. 1R13HL170501-01: Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment (2024-F1)*
National Institute on Aging (NIA)
Grant No. 1R13AG084266-01: Immunity and Aging (2024-F3)
Grant No. 1R13AR083220-01: Exercise Biology: Signaling, Mechanisms and Benefits (2024-Q1)*
2023 Conferences
National Cancer Institute (NCI)
Grant No. 1R13CA265047-01A1: Tumor Metabolism - RESCHEDULED (2023-RJ2)
Grant No. 1 R13 CA257245-01: Exosomes, Microvesicles and Other Extracellular Vesicles - RESCHEDULED (2023-RB3)
Grant No. 1R13CA275174-01: Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy (2023-A4)
Grant No. 1R13CA275175-01: Protein-RNA Interactions (2023-J8)
Grant No. 1R13CA278260-01: Genomic Instability and DNA Repair (2023-X1)
Grant No. 1R13CA281139-01: Metastasis (2023-Z1)
National Center for Advancing Translational Sciences (NCATS)
Grant No. 1R13TR003159-01: Targeted Protein Degradation - RESCHEDULED (2023-RJ6)
Grant No. 1 R13 AI167430-01: Novel Approaches Against Emerging Antimicrobial Resistance - RESCHEDULED (2023-RQ4)*
Grant No. 1R13NS129216-01: Drug Delivery to the Brain: Challenges and Progress (2023-A1)*
Grant No. 1R13TR004343-01: Organoids as Models of Development and Disease, and their Impact on Drug Discovery (2023-Q2)
Grant No. 1R13AI172245-01: Next Generation Antibody Therapeutics: From Discovery to Patient (2023-Q5)*
Grant No. 1 R13 TR004345-01: Precision Genome Engineering (2023-X2)
National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1R13HL154588-01: Heart Failure: Mechanisms and Therapies - RESCHEDULED (2023-RQ7)
Grant No. 1R13HL154801-01: Mitochondria, Metabolism and Heart - RESCHEDULED (2023-RQ8)
Grant No. 1R13HL154803-01A1: Heart Development and Disease: From Genes to Cures (2023-B1)
Grant No. 1R13HL168846-01: Fibrosis Pathogenesis and Resolution: From Mechanisms to Therapies (2023-X3)
Grant No. 1R13HL168845-01: From First Breath: Lung Development, Infection, Repair and Aging (2023-X7)
Grant No. 1R13HL168861-01: Heart Failure: All Cells Considered (2023-Z7)
Grant No. 1R13HL168939-01: Pulmonary Hypertension: State of the Art and Therapeutic Opportunities (2023-Z8)
National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1 R13 AI167433-01: A Research Reboot of Tuberculosis on the Keystone Symposia 50th Anniversary - RESCHEDULED (2023-RA3)
Grant No. 1 R13 AI167431-01: Immunometabolism at the Crossroads of Obesity and Cancer - RESCHEDULED (2023-RJ1)
Grant No. 1R13A172250-01: Neuroimmunometabolism - Obesity at the Crossroads between Neuroimmunity and Immunometabolism (2023-J1)
Grant No. 1 R13 AI167434-01: The Human Microbiome: Ecology and Evolution - RESCHEDULED (2023-RQ3)
Grant No. 1 R13 AI167430-01: Novel Approaches Against Emerging Antimicrobial Resistance - RESCHEDULED (2023-RQ4)
Grant No. 1R13Al172248-01: Inborn Errors of Immunity: From Genetics to Basic Immunological Principles to Therapy (2023-EK1)
Grant No. 1Rl 3AI172249-01: Infections in Pregnancy: Pathogenic Mechanisms, Experimental Advances and Clinical Strategies (2023-J6)
Grant No. 1R13AI154970-01: Vector Biology: Emerging Concepts and Novel Technologies (2023-Q4)
Grant No. 1R13AI172245-01: Next Generation Antibody Therapeutics: From Discovery to Patient (2023-Q5)
Grant No. 1R13AI174634-01: Myeloid Cells: Development, Diversity and Distinct Biological Roles (2023-D1)
Grant No. 1 R13 AI174639-01: Innate Immunity: From Innate Sensing to Adaptive Responses (2023-D2)
Grant No. 1R13AI176837-01: Inflammation in the Lung: Friend or Foe in Viral Infections? (2023-X8)
Grant No. 1R13AI176860-01: B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers (2023-Z5)
Grant No. 1R13AI176986-01: HIV Vaccines, Immunoprophylaxis and Drugs (2023-Z6)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Grant No. 1 R13 DK135318-01: Bioenergetics in Health and Diseases (2023-J4)*
Grant No. 1R13AR078065-01: Skin-Immune Crosstalk (2023-Q3)
Grant No. 1R13AI154970-01: Vector Biology: Emerging Concepts and Novel Technologies (2023-Q4)*
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Grant No. 1R13CA275174-01: Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy (2023-A4)*
Grant No. 1R13HL168939-01: Pulmonary Hypertension: State of the Art and Therapeutic Opportunities (2023-Z8)*
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 1 R13 DK131814-01: Inter Organ Crosstalk in Non-Alcoholic Steatohepatitis (NASH) - RESCHEDULED (2023-RQ1)
Grant No. 1 R13 DK131815-01: Adipose Tissue and Metabolic Health - RESCHEDULED (2023-RQ2)
Grant No. 1 R13 AI167431-01: Immunometabolism at the Crossroads of Obesity and Cancer - RESCHEDULED (2023-RJ1)*
Grant No. 1R13A172250-01: Neuroimmunometabolism - Obesity at the Crossroads between Neuroimmunity and Immunometabolism (2023-J1)*
Grant No. 1R13DK135317-01: Adipose Tissue: Energizing Good Fat (2023-J3)
Grant No. 1 R13 DK135318-01: Bioenergetics in Health and Diseases (2023-J4)
Grant No. 1R13DK136324-01: Metabolic and Molecular Mechanisms of NAFLD/NASH (2023-X4)
Grant No. 1R13DK136315-01: Type 2 Diabetes: Understanding its Early Drivers and the Road to Therapeutics (2023-E1)
National Institute of Mental Health (NIMH)
Grant No. 1R13MH131314-01: Neurocircuitry of Social Behavior (2023-S1)
National Institute of Neurological Disorders and Stroke (NINDS)
Grant No. 1R13NS129216-01: Drug Delivery to the Brain: Challenges and Progress (2023-A1)
Grant No. 1R13NS130935-01: Autophagy and Neurodegeneration: Mechanisms to Therapies (2023-C1)
National Institute on Aging (NIA)
Grant No. 1R13DK135317-01: Adipose Tissue: Energizing Good Fat (2023-J3)*
Grant No. 1R13CA278260-01: Genomic Instability and DNA Repair (2023-X1)*
Grant No. 1 R13 AG081119-01: Molecular Basis of Healthy Aging (2023-X6)
Office of the Director (OD)
Grant No. 1Rl 3AI172249-01: Infections in Pregnancy: Pathogenic Mechanisms, Experimental Advances and Clinical Strategies (2023-J6)*
Grant No. 1 R13 TR004345-01: Precision Genome Engineering (2023-X2)*
* Indicates Secondary Funding Institute for Grant
